Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome

BACKGROUND: We have investigated the use of nebulized surfactant as a potential therapeutic option for the patients with coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS) undergoing non-invasive ventilation. METHODS: The patients were divided into 2 groups: su...

Descripción completa

Detalles Bibliográficos
Autores principales: Avdeev, Sergey N., Trushenko, Natalia V., Chikina, Svetlana Yu, Tsareva, Natalia A., Merzhoeva, Zamira M., Yaroshetskiy, Andrey I., Sopova, Violetta I., Sopova, Margarita I., Rosenberg, Oleg A., Schermuly, Ralph Theo, Kosanovic, Djuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163691/
https://www.ncbi.nlm.nih.gov/pubmed/34087610
http://dx.doi.org/10.1016/j.rmed.2021.106489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163691/
https://www.ncbi.nlm.nih.gov/pubmed/34087610
http://dx.doi.org/10.1016/j.rmed.2021.106489

Ejemplares similares